Remove 2009 Related Topics
Biosimilars Insurance Coverage and Processing Diabetes Generic Medicine Pharmaceutical Companies Dosage Documentation Communication Adverse Reactions Labelling More Related Topics >
article thumbnail

STAT+: After Canada required pharma to pay fees, drug agency recommended coverage more often

STAT

MARCH 3, 2025

The analysis tallied a total of 258 approved drugs for which companies submitted applications between 2009 and 2020, and then examined funding recommendations that were subsequently made through December 2020 for most drugs. Recommendations for cancer treatments were reviewed through December 2021.

Drug Pricing 219
Drug Pricing 219
article thumbnail

Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData

Express Pharma

DECEMBER 18, 2024

Nelluri Geetha, Pharma Analyst at GlobalData, comments, South Korea has a long history in manufacturing biologicals and a regulatory pathway for biosimilars was introduced in South Korea in 2009.

Biosimilars 104
Biosimilars 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Negotiations Decoded: Lessons from the Trenches

Drug Patent Watch

JANUARY 14, 2025

Lessons from Past Pharmaceutical Negotiations Case Study: Merck and Schering-Plough Merger The 2009 merger between Merck and Schering-Plough, valued at $41.1 These may include: Pharmaceutical companies (big pharma and biotech firms) Contract research organizations (CROs) Regulatory bodies (e.g.,

Communication 54
Communication Pharmaceutical Companies Pharmaceutical Companies 54
article thumbnail

Pharmacogenomics

RX Note

DECEMBER 25, 2024

2009 Clopidogrel Therapy and CYP2C19 Genotype, 2018 EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine, 2020 Tramadol Therapy and CYP2D6 Genotype, 2021

Labelling 40
Labelling 40
article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Website and content copyright © 2009- 2025 , pharmaphorum media limited or its licensors; all rights reserved. Website and content copyright © 2009- 2025 , pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company The rights of trademark owners are acknowledged.

Health and Personal Care Stores 59
Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59
article thumbnail

Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing

European Pharmaceutical Review

APRIL 8, 2025

International Council for Harmonisation (ICH), 2009. Boca Raton: CRC Press. International Council for Harmonisation (ICH), 2022. Q2(R2) Validation of Analytical Procedures: Text and Methodology. Q8(R2) Pharmaceutical Development. International Council for Harmonisation (ICH), 2005. Q9 Quality Risk Management.

Documentation 52
Documentation Packaging Pharmaceutical Manufacturing 52
article thumbnail

QbD for biopharmaceutical product lifecycle management

European Pharmaceutical Review

APRIL 21, 2025

References Innovative Solutions For Bioprocessing Challenges: How MSAT Drives Efficient Tech Transfer. Internet] Samsung Biologics. Available from: [link] Guidance for Industry – Q8(R2) Pharmaceutical Development. Internet] FDA. Available from: [link] Strategic Biomanufacturing Framework And Technologies For Successful Partnership.

Customer Service 52
Customer Service Drug Development 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 11,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy | Cookie Settings
© Aggregage 2025